These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34098489)

  • 21. Casting a wider net: Immunosurveillance by nonclassical MHC molecules.
    D'Souza MP; Adams E; Altman JD; Birnbaum ME; Boggiano C; Casorati G; Chien YH; Conley A; Eckle SBG; Früh K; Gondré-Lewis T; Hassan N; Huang H; Jayashankar L; Kasmar AG; Kunwar N; Lavelle J; Lewinsohn DM; Moody B; Picker L; Ramachandra L; Shastri N; Parham P; McMichael AJ; Yewdell JW
    PLoS Pathog; 2019 Feb; 15(2):e1007567. PubMed ID: 30789961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing.
    Cifaldi L; Lo Monaco E; Forloni M; Giorda E; Lorenzi S; Petrini S; Tremante E; Pende D; Locatelli F; Giacomini P; Fruci D
    Cancer Res; 2011 Mar; 71(5):1597-606. PubMed ID: 21252114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.
    Yan J; Parekh VV; Mendez-Fernandez Y; Olivares-Villagómez D; Dragovic S; Hill T; Roopenian DC; Joyce S; Van Kaer L
    J Exp Med; 2006 Mar; 203(3):647-59. PubMed ID: 16505142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
    Reimann J; Böhm W; Schirmbeck R
    Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1.
    Jiang H; Chess L
    Annu Rev Immunol; 2000; 18():185-216. PubMed ID: 10837057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs.
    Bouwer HG; Seaman MS; Forman J; Hinrichs DJ
    J Immunol; 1997 Sep; 159(6):2795-801. PubMed ID: 9300701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nilabh Shastri - Towards understanding classical and non-classical MHC-I antigen processing and presentation.
    Kessler BM
    Cell Immunol; 2022 Dec; 382():104638. PubMed ID: 36371991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-conventional sources of peptides presented by MHC class I.
    Starck SR; Shastri N
    Cell Mol Life Sci; 2011 May; 68(9):1471-9. PubMed ID: 21390547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of protective antitumor immunity through attenuation of ERAAP function.
    James E; Bailey I; Sugiyarto G; Elliott T
    J Immunol; 2013 Jun; 190(11):5839-46. PubMed ID: 23610143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses.
    Spencer CT; Dragovic SM; Conant SB; Gray JJ; Zheng M; Samir P; Niu X; Moutaftsi M; Van Kaer L; Sette A; Link AJ; Joyce S
    Eur J Immunol; 2013 May; 43(5):1162-72. PubMed ID: 23386199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
    Griffiths E; Ong H; Soloski MJ; Bachmann MF; Ohashi PS; Speiser DE
    Cancer Res; 1998 Oct; 58(20):4682-7. PubMed ID: 9788622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1
    Doorduijn EM; Sluijter M; Querido BJ; Seidel UJE; Oliveira CC; van der Burg SH; van Hall T
    Front Immunol; 2018; 9():60. PubMed ID: 29422902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.
    Starck SR; Shastri N
    Immunol Rev; 2016 Jul; 272(1):8-16. PubMed ID: 27319338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Don't mess with ERAAP!
    Yewdell JW; Lu X
    Nat Immunol; 2012 May; 13(6):526-8. PubMed ID: 22610241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forcing tumor cells to present their own tumor antigens to the immune system: a necessary design for an efficient tumor immunotherapy.
    Humphreys RE; Hillman GG; von Hofe E; Xu M
    Cell Mol Immunol; 2004 Jun; 1(3):180-5. PubMed ID: 16219165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of nonclassical MHC-dependent invariant T cells.
    Edholm ES; Grayfer L; Robert J
    Cell Mol Life Sci; 2014 Dec; 71(24):4763-80. PubMed ID: 25117267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host immune response to intracellular bacteria: A role for MHC-linked class-Ib antigen-presenting molecules.
    Soloski MJ; Szperka ME; Davies A; Wooden SL
    Proc Soc Exp Biol Med; 2000 Sep; 224(4):231-9. PubMed ID: 10964257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8
    Abdulhaqq SA; Wu H; Schell JB; Hammond KB; Reed JS; Legasse AW; Axthelm MK; Park BS; Asokan A; Früh K; Hansen SG; Picker LJ; Sacha JB
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.